ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Discussion
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mikko J. Hippeläinen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jokinen, J. J.
Right arrow Articles by Hartikainen, J. E.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jokinen, J. J.
Right arrow Articles by Hartikainen, J. E.K.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2007;84:451-458
© 2007 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Mitral Valve Replacement Versus Repair: Propensity-Adjusted Survival and Quality-of-Life Analysis

Janne J. Jokinen, MDa, Mikko J. Hippeläinen, MD, PhDb,*, Otto A. Pitkänen, MD, PhDc, Juha E.K. Hartikainen, MD, PhDd

a Department of Cardiothoracic Surgery, Helsinki University Hospital, Helsinki, Finland
b Department of Surgery, Kuopio University Hospital, Kuopio, Finland
c Department of Anesthesiology, Kuopio University Hospital, Kuopio, Finland
d Department of Cardiology, Kuopio University Hospital, Kuopio, Finland

Accepted for publication March 20, 2007.

* Address correspondence to Dr Hippeläinen, Department of Surgery, Kuopio University Hospital, PO Box 1777, Kuopio, FIN-70211, Finland (Email: mikko.hippelainen{at}kuh.fi).

Background: We investigated whether mitral valve repair (MVP) is superior to mitral valve replacement (MVR) in terms of survival and quality of life during the long-term follow-up.

Methods: One hundred eighty-four consecutive patients underwent MVP or MVR for mitral regurgitation with or without concomitant coronary artery bypass grafting. Clinical data were recorded prospectively, and the data for the Nottingham Health Profile quality-of-life analysis was collected cross-sectionally. Propensity score analysis was used for the study group matching.

Results: The mean follow-up time was 7.3 ± 1.4 years. After adjustment for baseline characteristics by the propensity score method, there was a statistically significant survival benefit for the patients who underwent MVP (p = 0.02). Risk factors for death were preoperative unstable angina pectoris (relative risk ratio, 4.4; 95% confidence interval, 2.2 to 8.8), age older than 60 years (relative risk ratio, 1.1; 95% confidence interval, 1.0 to 1.1), use of mitral prosthesis (relative risk ratio, 2.7; 95% confidence interval, 1.4 to 5.3), preoperative renal insufficiency (relative risk ratio, 1.0; 95% confidence interval, 1.0 to 1.007), and preoperative cerebrovascular disorder (relative risk ratio, 2.7; 95% confidence interval, 1.0 to 5.3). The quality of life of the MVP and MVR groups did not differ from each other, but the MVP and the MVR patients had lower energy and mobility scores than an age- and sex-matched reference population.

Conclusions: Survival is longer after MVP than after MVR. The quality of life of MVP and MVR patients does not differ from each other. In terms of most quality-of-life variables, patients who undergo mitral valve operations cope similarly to an age- and sex-matched reference population. Only the scores reflecting energy and mobility were lower in the patients who were operated on than in the reference population.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. D. Barnett and N. Ad
Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005.
J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1422 - 1429.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. S. Gammie, S. Sheng, B. P. Griffith, E. D. Peterson, J. S. Rankin, S. M. O'Brien, and J. M. Brown
Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database.
Ann. Thorac. Surg., May 1, 2009; 87(5): 1431 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Di Stefano, J. Lopez, S. Florez, J. Rey, A. Arevalo, and A. San Roman
Building a new annulus: a technique for mitral valve replacement in heavily calcified annulus.
Ann. Thorac. Surg., May 1, 2009; 87(5): 1625 - 1627.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
J. J. Jokinen, M. J. Hippelainen, T. Hanninen, A. K. Turpeinen, and J. E.K. Hartikainen
Prospective assessment of quality of life of octogenarians after cardiac surgery: factors predicting long-term outcome
Interactive CardioVascular and Thoracic Surgery, October 1, 2008; 7(5): 813 - 818.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. A. Carabello
The Current Therapy for Mitral Regurgitation
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 319 - 326.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W.M. Fedak, P. M. McCarthy, and R. O. Bonow
Evolving Concepts and Technologies in Mitral Valve Repair
Circulation, February 19, 2008; 117(7): 963 - 974.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.